Jul 3, 2015
Sequencing Study Sees Frequent RAS-MAPK Mutations at Neuroblastoma Relapse
In Nature Genetics, an international team led by investigators in the US, Netherlands, and France pinpointed a role for the RAS-MAPK...
Apr 14, 2015
New pediatric cancer drug shows promising results for Austin boy
A new cancer treatment for children recently approved by the Food and Drug Administration is just the third pediatric cancer drug OK’d in...
Mar 11, 2015
FDA clears first therapy for rare childhood cancer
United Therapeutics' Unituxin has become the first-ever therapy approved in the US for neuroblastoma, a rare form of cancer that most...
Nov 11, 2014
Classification of gene mutations in a children's cancer may point to improved treatments
Oncology researchers studying gene mutations in the childhood cancer neuroblastoma are refining their diagnostic tools to predict which...
Nov 11, 2014
Seattle Children’s Begins Recruiting Patients for Immunotherapy Research Trial for Neuroblastoma, On
Seattle Children’s today announced the opening of patient enrollment for its new cellular immunotherapy clinical research trial designed...
Oct 24, 2014
Researchers identify new target for treating childhood cancers
Scientists at the University of Liverpool have uncovered a new target for drugs that could battle a lethal childhood cancer known as...
Oct 6, 2014
FDA grants orphan drug designation for neuroblastoma vaccine
The U.S. Food and Drug Administration (FDA) granted orphan drug designation for a neuroblastoma vaccine from MabVax Therapeutics,...
Jul 31, 2014
New DNA technology may improve the treatment of aggressive childhood cancer
Neuroblastoma, a form of cancer, is the most common childhood tumour outside of the brain, and the one that has been the most difficult...
May 9, 2014
Experimental antibody shows early promise for treatment of childhood tumor
Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a...
May 5, 2014
Children's Oncology Drug Alliance (CODA) Formed to Facilitate Development of Treatments for Chil
Alliance of Australian and U.S. researchers and children's cancer advocates focused on developing drugs as potential treatments for...